Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effectiveness of Atomoxetine and Amantadine in the Level of Consciousness of Patients with Traumatic Brain Injury
IRCT20221101056357N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in traumatic brain injury (TBI) comparing Atomoxetine arm with Amantadine arm (2 arms). Started May 2026; status: completed.
02
Drugs
atomoxetineamantadine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20221101056357N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221101056357N2.